Asian Penny Stocks To Watch In April 2026

Amidst ongoing geopolitical tensions and energy market volatility, Asian markets have been navigating a complex landscape, with investors closely monitoring developments that could impact regional economies. Penny stocks, though often seen as relics of past investment trends, continue to offer intriguing opportunities for those looking beyond the mainstream. These stocks typically represent smaller or newer companies and can provide growth potential at lower price points when backed by strong fundamentals.

Top 10 Penny Stocks In Asia

Name	Share Price	Market Cap	Rewards & Risks
North East Rubber (SET:NER)	THB4.88	THB9.02B	✅ 5 ⚠️ 2 View Analysis >
Asia Medical and Agricultural Laboratory and Research Center (SET:AMARC)	THB3.40	THB1.42B	✅ 3 ⚠️ 3 View Analysis >
YesAsia Holdings (SEHK:2209)	HK$3.19	HK$1.33B	✅ 4 ⚠️ 3 View Analysis >
PC Partner Group (SGX:PCT)	SGD1.58	SGD612.86M	✅ 4 ⚠️ 2 View Analysis >
CNMC Goldmine Holdings (Catalist:5TP)	SGD1.53	SGD620.09M	✅ 4 ⚠️ 2 View Analysis >
Atlantic Navigation Holdings (Singapore) (Catalist:5UL)	SGD0.122	SGD63.87M	✅ 1 ⚠️ 5 View Analysis >
Yangzijiang Shipbuilding (Holdings) (SGX:BS6)	SGD3.99	SGD15.7B	✅ 4 ⚠️ 2 View Analysis >
TeleChoice International (SGX:T41)	SGD0.197	SGD89.51M	✅ 4 ⚠️ 2 View Analysis >
Bosideng International Holdings (SEHK:3998)	HK$4.18	HK$48.58B	✅ 4 ⚠️ 2 View Analysis >
Scott Technology (NZSE:SCT)	NZ$2.42	NZ$203.51M	✅ 4 ⚠️ 0 View Analysis >

Click here to see the full list of 927 stocks from our Asian Penny Stocks screener.

Underneath we present a selection of stocks filtered out by our screen.

Meitu (SEHK:1357)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Meitu, Inc. is an investment holding company that develops and provides products for photo, video, and design production along with other AI-powered products in Mainland China and internationally, with a market cap of HK$21.65 billion.

Operations: The company's revenue primarily comes from its Internet Business segment, generating CN¥3.86 billion.

Market Cap: HK$21.65B

Meitu, Inc. has shown a mixed financial performance, with revenues of CN¥3.86 billion and net income decreasing to CN¥582.9 million for 2025. Despite high-quality earnings and strong cash flow covering debt, the company's profit margins have declined from last year. The stock trades significantly below its estimated fair value, suggesting potential undervaluation in the market. Meitu's management team is experienced, and its board tenure reflects stability; however, recent negative earnings growth contrasts with past profitability improvements. A proposed dividend decrease and share buyback program highlight efforts to enhance shareholder value amidst these challenges.

• Unlock comprehensive insights into our analysis of Meitu stock in this financial health report.
• Gain insights into Meitu's outlook and expected performance with our report on the company's earnings estimates.

China Ruyi Holdings (SEHK:136)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: China Ruyi Holdings Limited is an investment holding company involved in content production and online streaming across Mainland China, Hong Kong, Europe, and other international markets, with a market cap of HK$26.38 billion.

Operations: The company's revenue is primarily derived from its content production business, which generated CN¥678.41 million, and its online streaming and online gaming businesses, which collectively contributed CN¥2.64 billion.

Market Cap: HK$26.38B

China Ruyi Holdings Limited has experienced a turnaround, reporting a net income of CN¥1.8 billion for 2025 after a loss the previous year. The company's revenue, primarily from content production and online streaming, totaled CN¥3.34 billion but decreased from the prior year. Despite this, its financial health remains robust with short-term assets significantly exceeding liabilities and more cash than total debt. However, earnings were impacted by a large one-off gain of CN¥1.3 billion, suggesting volatility in core operations. The stock trades well below estimated fair value, indicating potential undervaluation despite its low return on equity at 7.5%.

• Click here and access our complete financial health analysis report to understand the dynamics of China Ruyi Holdings.
• Explore China Ruyi Holdings' analyst forecasts in our growth report.

Delfi (SGX:P34)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Delfi Limited is an investment holding company that manufactures, markets, distributes, and sells chocolate and confectionery products across Indonesia, the Philippines, Malaysia, Singapore, and internationally with a market cap of SGD702.83 million.

Operations: The company's revenue is primarily derived from its operations in Indonesia, generating $329.06 million, and its regional markets, contributing $198.82 million.

Market Cap: SGD702.83M

Delfi Limited, with a market cap of SGD702.83 million, operates primarily in Indonesia and regional markets, generating revenues of US$500.09 million in 2025. Despite a slight decline in net income to US$33.23 million, the company maintains strong financial health with short-term assets exceeding both short and long-term liabilities and more cash than total debt. Its operating cash flow significantly covers its debt obligations at a very large percentage, while the management team is experienced with an average tenure of 5.7 years. Delfi's stock trades substantially below estimated fair value but faces challenges due to unstable dividend history and low return on equity at 11.9%.

• Click here to discover the nuances of Delfi with our detailed analytical financial health report.
• Assess Delfi's future earnings estimates with our detailed growth reports.

Taking Advantage

• Reveal the 927 hidden gems among our Asian Penny Stocks screener with a single click here.
• Want To Explore Some Alternatives? Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com